Annalisa Jenkins insider trades

Open-market stock purchases and sales by Annalisa Jenkins, Director at Skye Bioscience, Inc, from SEC Form 4 filings since Apr 20, 2015.

Recent trades

DateStockTradeValue
Mar 31, 2026SKYE Skye Bioscience, IncBought (not open market)—
Feb 26, 2026MREO Mereo BioPharma Group plcBought (not open market)—
Feb 26, 2026MREO Mereo BioPharma Group plcBought (not open market)—
Feb 6, 2026SKYE Skye Bioscience, IncBought (not open market)—

Companies traded

  • SKYE Skye Bioscience, Inc: other filings, last Mar 31, 2026
  • MREO Mereo BioPharma Group plc: other filings, last Feb 26, 2026
  • CMPS COMPASS Pathways plc: 1 sale, last Jun 12, 2025
  • AVRO AVROBIO, Inc: other filings, last Jun 6, 2023
  • AGE AgeX Therapeutics, Inc: other filings, last Jun 21, 2021
  • ARDX Ardelyx, Inc: other filings, last Jun 13, 2019
  • DMTX Dimension Therapeutics, Inc: other filings, last Nov 7, 2017
  • ONCS ONCOSEC MEDICAL Inc: other filings, last Sep 5, 2017

Get free alerts when Annalisa Jenkins files a new trade →